Peel Hunt has been appointed as joint Corporate Broker to AIM-listed Clinigen Group plc. Clinigen is a specialty global pharmaceutical company headquartered in the UK, with offices in the US and Japan, and has three operating businesses: Specialty Pharmaceuticals, Clinical Trials Supply, and Global Access Programs.
